...According to Hickman, what sets Hesperos apart from other companies developing multi-organ systems, including Emulate Inc.,TissUse GmbH...
...and noted that measuring biomarkers enables translation to clinical trials that use those as endpoints. TissUse...
...Hesperos Inc., Orlando, Fla. National Institutes of Health, Bethesda, Md. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland TissUse GmbH...

...kidney-liver interaction Primary cells; iPS cells Tara Biosystems Inc. Biowire II cardiovascular model iPS cells TissUse GmbH...
...provides temperature control. TissUse is one of at least ten companies developing organ-on-chip technology. Source: TissUse GmbH...
...with big data sets and get them hands on experience.” Reyk Horland, TissUse This week, TissUse...

...gut, liver and kidneys, and is also developing skin, eye and BBB chips (not shown). TissUse GmbH...

...biology include the microfluidics-based organ-on-a-chip models being developed by Emulate Inc. , Mimetas B.V. and TissUse GmbH...
...Bethesda, Md. National Institutes of Health , Bethesda, Md. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland TissUse GmbH...

...developing their own versions of organs-on-chips include TissUse GmbH , Mimetas B.V. , and Nortis Inc. TissUse...
...University , Cambridge, Mass. Mimetas B.V. , Leiden, the Netherlands Nortis Inc. , Seattle, Wash. TissUse GmbH...

...platform prior to launch. Several other companies are developing versions of the organs-on-chips technology, including TissUse GmbH...

...an array. This "human-on-a-chip" could eventually supplement or replace some preclinical and clinical safety testing. TissUse's...
...microfluidic channel system. The chip emulates the fluid dynamics and fluid-to-tissue ratios of human biology. TissUse's...
...priority organ for pharma" because it is the prime metabolic organ for drugs. According to TissUse...